The inability to diagnose PiD in life, in combination with its rarity, has contributed to our lack of understanding of disease risk factors and modifiers and biological processes that contribute to disease pathogenesis or that are dysregulated as a result of 3R tau pathology. The gene discussed is MAPT; the disease is pelvic inflammatory disease.